Having trouble viewing this email? View the online version.
ISSM logo

Latest News from the ISSM - August 3, 2012 Member Login
World Meeting on Sexual Medicine - Helpful Links

There's less than a month to go before we start the World Meeting on Sexual Medicine! The meeting will be held August 26 - 30.

While you can get all the current information you need about the meeting here, we thought it would be helpful to provide the direct links to some common questions:


What are the registration fees?

How do I register for the meeting?

Venue/Chicago Information

Where is the hotel?

How do I make make my hotel reservation(s)?

How do I get to the meeting?

What can I do for recreation in Chicago?


Where can I get details on the scientific program and symposia?

Who are the invited speakers?

Which abstracts will be presented?

Which abstracts will be presented as unmoderated posters?

CME and Prizes

Where can I learn more about CME accreditation?

Which prizes will be awarded at the meeting?

If you have questions that aren't addressed here or on the meeting website, please feel free to contact us at chicago2012@issm.info.

Peyronie's Disease and Xiaflex

In time, the drug Xiaflex may become an FDA-approved treatment option for men with Peyronie's disease in the United States.

Peyronie's disease occurs when areas of hardened scar tissue called plaques form on the penis. The result is a curvature that can make intercourse difficult.  

Auxilium Pharmaceuticals, the maker of Xiaflex, recently announced the results of its Phase III clinical trials of the drug.  Two groups of approximately 400 men each participated.                                                 

The researchers found that the men who had injections of Xiaflex had greater reductions in curvature than the men who were given a placebo.

The men who took Xiaflex also reported less pain and fewer psychological and physical symptoms.  

The manufacturer plans to apply for FDA approval for Xiaflex and the treatment of Peyronie's disease later this year. If approved, Xiaflex can be marketed for that purpose in the U.S.

To learn more about Xiaflex, how it works, its side effects, and the recent clinical trials, click here.

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

ISSM | International Society for Sexual Medicine
P.O. Box 94 | 1520 AB Wormerveer | The Netherlands